DNA2L Inhibitors
DNA2L, or DNA replication helicase/nuclease 2-like, plays a crucial role in the maintenance of genomic stability and the DNA replication process. It is a multifunctional enzyme that unwinds DNA and cleaves it, an activity that is essential during replication fork progression and the repair of damaged DNA. The expression of DNA2L is tightly regulated within the cell, as its activity is critical for ensuring accurate DNA replication and the prevention of genomic instability, which can lead to cell cycle arrest, senescence, or apoptosis. Given the pivotal role of DNA2L in cell division and genome maintenance, the regulation of its expression is of significant interest in the study of cellular homeostasis and the response to DNA damage.
Several chemical compounds have been identified to have potential effects on the expression of DNA2L, although their mechanisms of action are varied and complex. Compounds like quercetin and curcumin are known to interact with cellular signaling pathways and may lead to the downregulation of DNA2L by altering the transcriptional activity of genes. On the other hand, chemically diverse molecules such as 5-Fluorouracil and doxorubicin could potentially inhibit the expression of DNA2L through the induction of DNA damage and the subsequent activation of DNA damage response pathways, which can include the repression of DNA replication-related genes. Other compounds, like hydroxyurea, decrease the availability of essential substrates for DNA synthesis or directly interfere with enzymes responsible for maintaining DNA integrity, which could result in reduced expression of DNA2L due to the cellular response to these stressors. While these compounds have been observed to affect the expression of DNA2L, it is crucial to note that the exact interactions and their consequences on DNA2L expression levels are subject to ongoing research, and the elucidation of these biochemical pathways continues to be an area of significant scientific inquiry.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $110.00 $250.00 $936.00 $50.00 | 33 | |
Quercetin may downregulate DNA2L expression by hindering the activity of specific transcription factors or by initiating cellular pathways that lead to the suppression of DNA2L gene promoter activity, though the exact target and pathway require experimental validation. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol has the potential to reduce DNA2L expression by altering the activity of sirtuin proteins that are involved in histone deacetylation, which can lead to tighter chromatin structure and reduced access of transcription machinery to the DNA2L gene. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin could decrease DNA2L expression by inhibiting the activation of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB), which may otherwise promote the transcription of DNA2L. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $37.00 $152.00 | 11 | |
5-Fluorouracil may inhibit DNA2L expression by incorporating into RNA and disrupting the proper processing and translation of DNA2L mRNA, leading to a reduction in DNA2L protein levels. | ||||||
Doxorubicin | 23214-92-8 | sc-280681 sc-280681A | 1 mg 5 mg | $176.00 $426.00 | 43 | |
Doxorubicin can decrease DNA2L expression through the induction of DNA damage, triggering cell cycle arrest and possibly leading to the transcriptional repression of genes involved in DNA replication, including DNA2L. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $94.00 $213.00 | 33 | |
Methotrexate can lead to a reduction in DNA2L expression by decreasing the availability of purine and pyrimidine nucleotides, which are necessary for DNA synthesis and gene expression, through the inhibition of the folate pathway. | ||||||
Hydroxyurea | 127-07-1 | sc-29061 sc-29061A | 5 g 25 g | $78.00 $260.00 | 18 | |
Hydroxyurea might downregulate DNA2L expression by depleting the pool of deoxyribonucleotides available for DNA synthesis, which could initiate a cellular response that includes the repression of genes involved in DNA replication processes. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $58.00 $186.00 $94.00 | 21 | |
Camptothecin is known to inhibit topoisomerase I, leading to DNA damage. This genotoxic stress can activate checkpoint kinase pathways that result in the downregulation of genes implicated in DNA replication and repair, such as DNA2L. | ||||||
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $90.00 $204.00 | 13 | |
Triptolide can inhibit the transcriptional activity of RNA polymerase II, leading to a global decrease in mRNA synthesis, which could include the mRNA of DNA2L, thus reducing its expression. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D can intercalate into DNA and sterically inhibit the progression of RNA polymerase during transcription initiation and elongation, leading to a decrease in the transcription of numerous genes, potentially including DNA2L. | ||||||